tirzepatide vs glp Beyond glycemia: Comparing to GLP-1 analogues Tirzepatide vs. Semaglutide: Which GLP-1

M., Alasmari, R

Coverage often requires documented BMI criteria, evidence of weight-related comorbidities (type 2 diabetes, hypertension, sleep apnea), and sometimes documentation of prior failed weight loss attempts

Researchers who have studied it understand the core mechanism: GLP-1 receptor (GLP-1R) agonism produces glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon release from alpha cells, slows gastric emptying, and engages hypothalamic appetite circuits specifically the arcuate nucleus to reduce caloric intake through neuropeptide Y/AgRP suppression and POMC/CART activation

doi: 10.1016/j.jtemb.2020.126548